GL1X · GenesisL1 explorer

Research workbench

Fragment-based lead discovery of indazole-based compounds as axl kinase inhibitors

Analyse Fragment-based lead discovery of indazole-based compounds as axl kinase… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
7DXL
Type
protein
Length
517 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Tyrosine-protein kinase mer
EC
2.7.10.1
UniProt
Q12866
Ligands
E56
Pockets
4 · best druggability 0.69

Structure

x-ray diffraction · 2 distinct chains · 41% helix, 17% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ATyrosine-protein kinase mer (EC 2.7.10.1)protein26143% helix, 17% strandQ12866
BTyrosine-protein kinase mer (EC 2.7.10.1)protein25640% helix, 16% strandQ12866

Ligands and binding sites

  • E56 · 3-[4-[6-chloranyl-5-[[(3R)-pyrrolidin-3-yl]amino]-1H-indazol-3-yl]pyrazol-1-yl]benzenecarbonitrile · ligand · 2 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

4 pockets found on a 1 Å grid, 4 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
14160.690.8141E56
22780.650.8135E56
31510.600.8418empty
42090.510.7735empty

Interfaces

1 interface between chains.

  • A–B · 1055 Ų buried · 11 hydrogen bonds · protein-protein

Compared structures

  • 7DXL · Fragment-based Lead Discovery of Indazole-based Compounds as AXL Kinase Inhibitors · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.